Ivan Babić
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism 4
- Molecular Biology top 10%
- Ubiquitin and proteasome pathways 5
- RNA modifications and cancer 5
- Biochemical and Molecular Research 3
- Genetics top 10%
-
- Immunotherapy and Immune Responses 4
-
- Monoclonal and Polyclonal Antibodies Research 7
-
- CAR-T cell therapy research 5
-
- Synthesis and biological activity 3
Ivan Babić
48 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 105
- Cancer Research 278
- Molecular Biology 874
- Genetics 115
- Aging 17
- Immunology 187
Countries citing papers authored by Ivan Babić
This map shows the geographic impact of Ivan Babić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan Babić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan Babić more than expected).
Fields of papers citing papers by Ivan Babić
This network shows the impact of papers produced by Ivan Babić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan Babić. The network helps show where Ivan Babić may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ivan Babić, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 4 | |
| 7 | 2020 | 17 | |
| 8 | 2018 | 6 | |
| 9 | 2018 | 3 | |
| 10 | 2017 | 18 | |
| 11 | 2015 | 19 | |
| 12 | 2014 | 6 | |
| 13 | 2013 | 341 | |
| 14 | 2013 | 25 | |
| 15 | 2013 | 96 | |
| 16 | 2011 | 46 | |
| 17 | 2010 | 82 | |
| 18 | 2006 | 61 | |
| 19 | 2004 | 75 | |
| 20 | 1996 | 37 |
About Ivan Babić
Ivan Babić is a scholar working on Aging, Oncology, Cancer Research, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 49 papers that have together received 1.2k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (7 papers), Ubiquitin and proteasome pathways (5 papers), CAR-T cell therapy research (5 papers), RNA modifications and cancer (5 papers), Immunotherapy and Immune Responses (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), Synthesis and biological activity (3 papers) and Biochemical and Molecular Research (3 papers). The work is most often cited by research in Cancer Research (278 citations), Molecular Biology (874 citations), Genetics (115 citations), Aging (17 citations) and Immunology (187 citations). Ivan Babić has collaborated with scholars based in United States, Croatia and Canada. Frequent co-authors include Frank R. Jirik, Paul S. Mischel, Webster K. Cavenee, Akio Iwanami, Andrew Jakymiw, Donald J. Fujita, Santosh Kesari, Jacqueline E. Damen, Elana Cherry and Ling Liu. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Scientific Reports, Human Antibodies and Acta Oto-Laryngologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.